-

Curant Health Releases Case Study: How Medication Care Management Transforms Heart Failure Care and Cuts Costs in Rural Wisconsin Community

ATLANTA--(BUSINESS WIRE)--PlanPlus by Curant Health today announced the release of a new case study highlighting how its Medication Care Management (MCM®) program helped Security Health Plan improve outcomes for members living with heart failure while significantly reducing total cost of care across a rural Wisconsin population.

"For a rural population with complex needs, the longitudinal engagement Curant provides filled a critical gap. Members weren't just receiving needed medications, they were supported by clinicians who understood their barriers and helped them stay well..."

Share

The case study, titled "How Medication Care Management Transforms Heart Failure Care and Cuts Costs in Rural Wisconsin Community," details the results of a collaboration between Security Health Plan and PlanPlus by Curant Health. The study examines how proactive medication care management, predictive analytics, and longitudinal clinical engagement improved medication adherence, reduced hospital utilization, and generated substantial cost savings. The full case study is available online at: https://theplanplus.com/project/case-study-how-medication-care-management-transforms-heart-failure-care-and-cuts-costs-in-rural-wisconsin-community/

In 2023, Security Health Plan (SHP) collaborated with PlanPlus by Curant Health to address rising Total Cost of Care (TCOC) among members diagnosed with Congestive Heart Failure (CHF). Heart failure remains one of the most resource-intensive chronic conditions in the United States, with costs often compounded in rural communities where barriers to care can negatively impact medication adherence and health outcomes.

To address these challenges, PlanPlus deployed its validated, proprietary Medication Care Management® (MCM®) program to proactively identify, resolve, and prevent medication-related and health-related issues among SHP's heart failure population. The program was designed to improve medication adherence, reduce avoidable hospital utilization, and lower downstream medical spending through relationship-based clinical engagement.

Year One Results

Across the intervention population, PlanPlus delivered an average per-member-per-month (PMPM) Total Cost of Care reduction of $585.98, driven primarily by reductions in medical spending associated with fewer hospitalizations and emergency department visits. The program generated an estimated 5:1 return on investment for Security Health Plan.

Additional results included:

  • Medication adherence improved to 90.6%
  • Hospital admissions decreased by 39.5%
  • Emergency room visits decreased by 15.6%
  • Medical PMPM costs decreased by $694.79
  • Improved adherence and optimized therapy resulted in a modest pharmacy PMPM increase of $108.81

The study attributes these outcomes to a combination of predictive analytics, daily claims-based monitoring, and ongoing member engagement conducted through Curant Health's multidisciplinary Member Experience and Outcomes Team (MEOT).

"For a rural population with complex needs, the longitudinal engagement Curant provides filled a critical gap. Members weren't just receiving needed medications, they were supported by clinicians who understood their barriers and helped them stay well between visits," said John Cox, Medical Director, Security Health Plan.

"In an industry where member complaints can be common, Curant Health has distinguished itself as a consistently high-performing solution with an exceptional complaints record, delivering quality, trust, and outstanding service to our members," said Paula Jacobson, Director, Quality and Population Health, Security Health Plan.

The case study concludes that precision clinical engagement combined with predictive analytics can meaningfully reduce Total Cost of Care while improving outcomes for rural heart failure populations. The collaboration has continued into its second year, with Security Health Plan expanding the program to additional heart failure members.

Authors

Jeremy Combs, MBA

John Cox, MD

Paula Jacobson

Contacts

Media Contact
Tim Griffin
Curant Health
tgriffin@curanthealth.com

Curant Health LogoCurant Health Logo

Curant Health


Release Versions

Contacts

Media Contact
Tim Griffin
Curant Health
tgriffin@curanthealth.com

Social Media Profiles
More News From Curant Health

Curant Rare Announces Collaboration with Cencora to Support Commercialization of Rare and Orphan Drug Products

ATLANTA--(BUSINESS WIRE)--Curant Rare today announced a strategic collaboration with Cencora, a global pharmaceutical solutions organization, that aims to provide pharmaceutical companies developing rare disease therapies with an integrated solution to support the commercialization of their products. Rare disease therapies face unique challenges, including complex regulatory pathways and access barriers. This collaboration will leverage Cencora’s pharmaceutical logistics services and commercial...

Curant Rare Announces Pharmacy Partnership with Corcept Therapeutics

ATLANTA--(BUSINESS WIRE)--Curant Health is proud to announce that Curant Rare has been selected by Corcept Therapeutics as a specialty pharmacy to provide personalized care, coordinated access to therapy, and comprehensive support to help patients and caregivers navigate the complexities of treatment. Patients will now benefit from Curant Rare’s proven high-touch care model, designed to ensure timely access to medication, address treatment barriers such as insurance and financial concerns, and...

Curant Rare Announces Exclusive Pharmacy Partnership for IWILFIN™, the First and Only FDA-Approved Oral Maintenance Therapy Shown to Cut the Risk of High-Risk Neuroblastoma Relapse in Half

ATLANTA--(BUSINESS WIRE)--Curant Health is proud to announce that Curant Rare is now the exclusive pharmacy partner for IWILFIN™, a groundbreaking therapy used to reduce the risk of relapse in adults and children with high-risk neuroblastoma (HRNB). Beginning in August 2025, patients will transition to Curant Rare with one clear goal in mind: to ensure uninterrupted access to care while enhancing the patient and caregiver experience through the IWILFIN Cares® program. All patients will continue...
Back to Newsroom